REPORTS

Let’s Pullulate and Expand Your Business

Global Vaccine Adjuvants Market Professional Research Report 2014-2026, Segmented by Players, Types, End-Users in Major 40 Countries or Regions

Nov 13, 2019  |  211 PAGES  |  REPORT CODE: CMM235246
  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • INDUSTRY COVERAGE

The Vaccine Adjuvants is expected to grow from USD 652 million in 2018 to 1319 million by 2025, at a Compound Annual Growth Rate (CAGR) of 10.6% during the forecast period. The research provides insights for the global Vaccine Adjuvants market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the Vaccine Adjuvants industry. For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global Vaccine Adjuvants Market Segmentations:

By Players:

  • Novavax

  • Adjuvatis

  • Merck KGaA

  • Oz Biosciences

  • Aphios

  • Seppic

  • SPI Pharma

  • Chemtrade Logistics

  • CSL Limited

  • Agenus, Inc.

  • Invivogen

  • Brenntag AG

  • InvivoGen

  • Vaxliant

  • Adjuvance

  • GlaxoSmithKline

By Types:

  • Mineral Salt Based Adjuvants

  • Tensoactive Adjuvants

  • Emulsions

  • Liposomes

  • Carbohydrates Adjuvants

  • Bacteria-Derived Adjuvants

  • Organic Adjuvants

  • Virus-Like Particles

  • Others

By End-User:

  • Infectious Disease

  • Therapeutic

  • Others

By Regions:

North America

  • United States

  • Canada

  • Mexico

Europe

  • Germany

  • UK

  • France

  • Italy

  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

  • Spain

  • Belgium

  • Poland

  • Russia

  • Turkey

  • Others

Asia-Pacific

  • China

  • Japan

  • India

  • South Korea

  • Australia and New Zealand

  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)

  • Brazil

  • Nigeria

  • South Africa

  • Argentina

  • Others

Table of Contents

1 Report Overview

  • 1.1 Product Definition and Scope

  • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Vaccine Adjuvants Market

  • 1.3 Market Segmentation by Type

    • 1.3.1 Global Vaccine Adjuvants Market Share by Types

    • 1.3.2 Global Vaccine Adjuvants Market Size and Growth Rate of Mineral Salt Based Adjuvants from 2014 to 2026

    • 1.3.3 Global Vaccine Adjuvants Market Size and Growth Rate of Tensoactive Adjuvants from 2014 to 2026

    • 1.3.4 Global Vaccine Adjuvants Market Size and Growth Rate of Emulsions from 2014 to 2026

    • 1.3.5 Global Vaccine Adjuvants Market Size and Growth Rate of Liposomes from 2014 to 2026

    • 1.3.6 Global Vaccine Adjuvants Market Size and Growth Rate of Carbohydrates Adjuvants from 2014 to 2026

    • 1.3.7 Global Vaccine Adjuvants Market Size and Growth Rate of Bacteria-Derived Adjuvants from 2014 to 2026

    • 1.3.8 Global Vaccine Adjuvants Market Size and Growth Rate of Organic Adjuvants from 2014 to 2026

    • 1.3.9 Global Vaccine Adjuvants Market Size and Growth Rate of Virus-Like Particles from 2014 to 2026

    • 1.3.10 Global Vaccine Adjuvants Market Size and Growth Rate of Others from 2014 to 2026

  • 1.4 Market Segmentation by End-Users

    • 1.4.1 Global Vaccine Adjuvants Market Share by End-Users

    • 1.4.2 Global Vaccine Adjuvants Market Size and Growth Rate of Infectious Disease from 2014 to 2026

    • 1.4.3 Global Vaccine Adjuvants Market Size and Growth Rate of Therapeutic from 2014 to 2026

    • 1.4.4 Global Vaccine Adjuvants Market Size and Growth Rate of Others from 2014 to 2026

  • 1.5 Market Segmentation by Regions

    • 1.5.1 North America Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.1 United States Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.2 Canada Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.1.3 Mexico Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • 1.5.2 Europe Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.1 Germany Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.2 UK Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.3 France Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.4 Italy Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.5 Nordic Countries Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.6 Spain Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.7 Belgium Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.8 Poland Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.9 Russia Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.2.10 Turkey Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • 1.5.3 Asia-Pacific Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.1 China Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.2 Japan Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.3 Australia and New Zealand Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.4 India Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.5 ASEAN Countries Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.3.6 South Korea Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

    • 1.5.4 Latin America, Middle East & Africa Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.1 GCC Countries Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.2 Brazil Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.3 Nigeria Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.4 South Africa Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

      • 1.5.4.5 Argentina Vaccine Adjuvants Market Size and Growth Rate from 2014 to 2026

2 Market Trends and Competitive Landscape

  • 2.1 Market Trends and Dynamics

    • 2.1.1 Market Challenges and Restraints 

    • 2.1.2 Market Opportunities and Potentials

    • 2.1.3 Mergers and Acquisitions

  • 2.2 Competitive Landscape Analysis

    • 2.2.1 Industrial Concentration Analysis

    • 2.2.2 Porter's Five Forces Analysis of the Industry

    • 2.2.3 SWOT Analysis for New Entrants

3 Segmentation of Vaccine Adjuvants Market by Types

  • 3.1 Product Development Trends of Different Types

  • 3.2 Commercial Product Types of Major Vendors

  • 3.3 Competitive Landscape Analysis of Different Types

  • 3.4 Market Size of Vaccine Adjuvants by Major Types

    • 3.4.1 Market Size and Growth Rate of Mineral Salt Based Adjuvants

    • 3.4.2 Market Size and Growth Rate of Tensoactive Adjuvants

    • 3.4.3 Market Size and Growth Rate of Emulsions

    • 3.4.4 Market Size and Growth Rate of Liposomes

    • 3.4.5 Market Size and Growth Rate of Carbohydrates Adjuvants

    • 3.4.6 Market Size and Growth Rate of Bacteria-Derived Adjuvants

    • 3.4.7 Market Size and Growth Rate of Organic Adjuvants

    • 3.4.8 Market Size and Growth Rate of Virus-Like Particles

    • 3.4.9 Market Size and Growth Rate of Others

4 Segmentation of Vaccine Adjuvants Market by End-Users

  • 4.1 Downstream Client Analysis by End-Users

  • 4.2 Competitive Landscape Analysis of Different End-Users

  • 4.3 Market Potential Analysis of Different End-Users

  • 4.4 Market Size of Vaccine Adjuvants by Major End-Users

    • 4.4.1 Market Size and Growth Rate of Vaccine Adjuvants for Infectious Disease

    • 4.4.2 Market Size and Growth Rate of Vaccine Adjuvants for Therapeutic

    • 4.4.3 Market Size and Growth Rate of Vaccine Adjuvants for Others

5 Market Analysis by Major Regions

  • 5.1 Global Vaccine Adjuvants Production Analysis by Major Regions

  • 5.2 Global Vaccine Adjuvants Consumption Analysis by Major Regions

  • 5.3 Global Vaccine Adjuvants Production, Import, Consumption and Export Analysis by Regions

    • 5.3.1 North America Vaccine Adjuvants Production, Import, Consumption and Export Analysis 

    • 5.3.2 Europe Vaccine Adjuvants Production, Import, Consumption and Export Analysis

    • 5.3.3 Asia Pacific Vaccine Adjuvants Production, Import, Consumption and Export Analysis

    • 5.3.4 Latin America, Middle East & Africa Vaccine Adjuvants Production, Import, Consumption and Export Analysis

6 Product Commodity of Vaccine Adjuvants Market in Major Countries

  • 6.1 Top 5 Export Countries in Vaccine Adjuvants market from 2014 to 2019

    • 6.1.1 Top 5 Export Countries' Export Value Analysis in Vaccine Adjuvants market from 2014 to 2019

    • 6.1.2 Top 5 Export Countries'  Export Volume Analysis in Vaccine Adjuvants market from 2014 to 2019

  • 6.2 Top 5 Import Countries in Vaccine Adjuvants market from 2014 to 2019

    • 6.2.1 Top 5 Import Countries' Import Value Analysis in Vaccine Adjuvants market from 2014 to 2019

    • 6.2.2 Top 5 Import Countries' Import Volume Analysis in Vaccine Adjuvants market from 2014 to 2019

  • 6.3 Emerging Top 3 Export Countries Analysis

  • 6.4 Emerging Top 3 Import Countries Analysis

7 North America Vaccine Adjuvants Landscape Analysis

  • 7.1 North America Vaccine Adjuvants Landscape Analysis by Major Types

  • 7.2 North America Vaccine Adjuvants Landscape Analysis by Major End-Users

  • 7.3 North America Vaccine Adjuvants Landscape Analysis by Major Countries

    • 7.3.1 United States Vaccine Adjuvants Market Volume and Growth Rate

    • 7.3.2 Canada Vaccine Adjuvants Market Volume and Growth Rate

    • 7.3.3 Mexico Vaccine Adjuvants Market Volume and Growth Rate

8 Europe Vaccine Adjuvants Landscape Analysis

  • 8.1 Europe Vaccine Adjuvants Landscape Analysis by Major Types

  • 8.2 Europe Vaccine Adjuvants Landscape Analysis by Major End-Users

  • 8.3 Europe Vaccine Adjuvants Landscape Analysis by Major Countries

    • 8.3.1 Germany Vaccine Adjuvants Market Volume and Growth Rate

    • 8.3.2 UK Vaccine Adjuvants Market Volume and Growth Rate

    • 8.3.3 France Vaccine Adjuvants Market Volume and Growth Rate

    • 8.3.4 Italy Vaccine Adjuvants Market Volume and Growth Rate

    • 8.3.5 Nordic Countries Vaccine Adjuvants Market Volume and Growth Rate

    • 8.3.6 Spain Vaccine Adjuvants Market Volume and Growth Rate

    • 8.3.7 Belgium Vaccine Adjuvants Market Volume and Growth Rate

    • 8.3.8 Poland Vaccine Adjuvants Market Volume and Growth Rate

    • 8.3.9 Russia Vaccine Adjuvants Market Volume and Growth Rate

    • 8.3.10 Turkey Vaccine Adjuvants Market Volume and Growth Rate

9 Asia Pacific Vaccine Adjuvants Landscape Analysis

  • 9.1 Asia Pacific Vaccine Adjuvants Landscape Analysis by Major Types

  • 9.2 Asia Pacific Vaccine Adjuvants Landscape Analysis by Major End-Users

  • 9.3 Asia Pacific Vaccine Adjuvants Landscape Analysis by Major Countries

    • 9.3.1 China Vaccine Adjuvants Market Volume and Growth Rate

    • 9.3.2 Japan Vaccine Adjuvants Market Volume and Growth Rate

    • 9.3.3 Australia and New Zealand Vaccine Adjuvants Market Volume and Growth Rate

    • 9.3.4 India Vaccine Adjuvants Market Volume and Growth Rate

    • 9.3.5 ASEAN Countries Vaccine Adjuvants Market Volume and Growth Rate

    • 9.3.6 South Korea Vaccine Adjuvants Market Volume and Growth Rate

10 Latin America, Middle East & Africa Vaccine Adjuvants Landscape Analysis

  • 10.1 Latin America, Middle East & Africa Vaccine Adjuvants Landscape Analysis by Major Types

  • 10.2 Latin America, Middle East & Africa Vaccine Adjuvants Landscape Analysis by Major End-Users

  • 10.3 Latin America, Middle East & Africa Vaccine Adjuvants Landscape Analysis by Major Countries

    • 10.3.1 GCC Countries Vaccine Adjuvants Market Volume and Growth Rate

    • 10.3.2 Brazil Vaccine Adjuvants Market Volume and Growth Rate

    • 10.3.3 Nigeria Vaccine Adjuvants Market Volume and Growth Rate

    • 10.3.4 South Africa Vaccine Adjuvants Market Volume and Growth Rate 

    • 10.3.5 Argentina Vaccine Adjuvants Market Volume and Growth Rate

11 Major Players Profile

  • 11.1 Novavax

    • 11.1.1 Novavax Company Profile and Development Status

    • 11.1.2 Market Performance

    • 11.1.3 Product and Service Introduction

  • 11.2 Adjuvatis

    • 11.2.1 Adjuvatis Company Profile and Development Status

    • 11.2.2 Market Performance

    • 11.2.3 Product and Service Introduction

  • 11.3 Merck KGaA

    • 11.3.1 Merck KGaA Company Profile and Development Status

    • 11.3.2 Market Performance

    • 11.3.3 Product and Service Introduction

  • 11.4 Oz Biosciences

    • 11.4.1 Oz Biosciences Company Profile and Development Status

    • 11.4.2 Market Performance

    • 11.4.3 Product and Service Introduction

  • 11.5 Aphios

    • 11.5.1 Aphios Company Profile and Development Status

    • 11.5.2 Market Performance

    • 11.5.3 Product and Service Introduction

  • 11.6 Seppic

    • 11.6.1 Seppic Company Profile and Development Status

    • 11.6.2 Market Performance

    • 11.6.3 Product and Service Introduction

  • 11.7 SPI Pharma

    • 11.7.1 SPI Pharma Company Profile and Development Status

    • 11.7.2 Market Performance

    • 11.7.3 Product and Service Introduction

  • 11.8 Chemtrade Logistics

    • 11.8.1 Chemtrade Logistics Company Profile and Development Status

    • 11.8.2 Market Performance

    • 11.8.3 Product and Service Introduction

  • 11.9 CSL Limited

    • 11.9.1 CSL Limited Company Profile and Development Status

    • 11.9.2 Market Performance

    • 11.9.3 Product and Service Introduction

  • 11.10 Agenus, Inc.

    • 11.10.1 Agenus, Inc. Company Profile and Development Status

    • 11.10.2 Market Performance

    • 11.10.3 Product and Service Introduction

  • 11.11 Invivogen

    • 11.11.1 Invivogen Company Profile and Development Status

    • 11.11.2 Market Performance

    • 11.11.3 Product and Service Introduction

  • 11.12 Brenntag AG

    • 11.12.1 Brenntag AG Company Profile and Development Status

    • 11.12.2 Market Performance

    • 11.12.3 Product and Service Introduction

  • 11.13 InvivoGen

    • 11.13.1 InvivoGen Company Profile and Development Status

    • 11.13.2 Market Performance

    • 11.13.3 Product and Service Introduction

  • 11.14 Vaxliant

    • 11.14.1 Vaxliant Company Profile and Development Status

    • 11.14.2 Market Performance

    • 11.14.3 Product and Service Introduction

  • 11.15 Adjuvance

    • 11.15.1 Adjuvance Company Profile and Development Status

    • 11.15.2 Market Performance

    • 11.15.3 Product and Service Introduction

  • 11.16 GlaxoSmithKline

    • 11.16.1 GlaxoSmithKline Company Profile and Development Status

    • 11.16.2 Market Performance

    • 11.16.3 Product and Service Introduction

12 Data Source and Research Methodology

The List of Tables and Figures (Totals 92 Figures and 133 Tables)

  • Figure Product Picture

  • Figure Global Vaccine Adjuvants Market Size and Growth Rate of Mineral Salt Based Adjuvants from 2014 to 2026

  • Figure Global Vaccine Adjuvants Market Size and Growth Rate of Tensoactive Adjuvants from 2014 to 2026

  • Figure Global Vaccine Adjuvants Market Size and Growth Rate of Emulsions from 2014 to 2026

  • Figure Global Vaccine Adjuvants Market Size and Growth Rate of Liposomes from 2014 to 2026

  • Figure Global Vaccine Adjuvants Market Size and Growth Rate of Carbohydrates Adjuvants from 2014 to 2026

  • Figure Global Vaccine Adjuvants Market Size and Growth Rate of Bacteria-Derived Adjuvants from 2014 to 2026

  • Figure Global Vaccine Adjuvants Market Size and Growth Rate of Organic Adjuvants from 2014 to 2026

  • Figure Global Vaccine Adjuvants Market Size and Growth Rate of Virus-Like Particles from 2014 to 2026

  • Figure Global Vaccine Adjuvants Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by Type in 2014

  • Figure Market Share by Type in 2018

  • Figure Market Share by Type in 2026

  • Figure Global Vaccine Adjuvants Market Size and Growth Rate of Infectious Disease from 2014 to 2026

  • Figure Global Vaccine Adjuvants Market Size and Growth Rate of Therapeutic from 2014 to 2026

  • Figure Global Vaccine Adjuvants Market Size and Growth Rate of Others from 2014 to 2026

  • Figure Market Share by End-User in 2014

  • Figure Market Share by End-User in 2018

  • Figure Market Share by End-User in 2026

  • Figure North America Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure United States Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Canada Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Mexico Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Europe Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Germany Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure UK Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure France Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Italy Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Spain Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Belgium Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Poland Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Russia Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Turkey Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Asia-Pacific Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure China Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Japan Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Australia and New Zealand Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure India Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Korea Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Latin America, Middle East & Africa Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure GCC Countries Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Brazil Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Nigeria Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure South Africa Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Argentina Vaccine Adjuvants Consumption Market Size and Growth Rate from 2014 to 2026

  • Figure Development Trends and Industry Dynamics of Vaccine Adjuvants Industry

  • Figure Market Challenges and Restraints

  • Figure Market Opportunities and Potentials

  • Table Mergers and Acquisition

  • Figure Market Share of TOP 3 Players in 2018

  • Figure Market Share of TOP 5 Players in 2018

  • Figure Market Share of TOP 6 Players from 2014 to 2019

  • Figure Porter's Five Forces Analysis

  • Figure New Entrant SWOT Analysis

  • Table Specifications of Different Types of Vaccine Adjuvants

  • Figure Development Trends of Different Types

  • Table Commercial Products Types of Major Vendors

  • Figure Competitive Landscape Analysis of Different Types

  • Table Consumption of Vaccine Adjuvants by Different Types from 2014 to 2026

  • Table Consumption Share of Vaccine Adjuvants by Different Types from 2014 to 2026

  • Figure Market Size and Growth Rate of Mineral Salt Based Adjuvants

  • Figure Market Size and Growth Rate of Tensoactive Adjuvants

  • Figure Market Size and Growth Rate of Emulsions

  • Figure Market Size and Growth Rate of Liposomes

  • Figure Market Size and Growth Rate of Carbohydrates Adjuvants

  • Figure Market Size and Growth Rate of Bacteria-Derived Adjuvants

  • Figure Market Size and Growth Rate of Organic Adjuvants

  • Figure Market Size and Growth Rate of Virus-Like Particles

  • Figure Market Size and Growth Rate of Others

  • Table Downstream Client Analysis by End-Users

  • Figure Competitive Landscape Analysis of Different End-Users

  • Table Market Potential Analysis of Different End-Users

  • Table Consumption of Vaccine Adjuvants by Different End-Users from 2014 to 2026

  • Table Consumption Share of Vaccine Adjuvants by Different End-Users from 2014 to 2026

  • Figure Market Size and Growth Rate of Infectious Disease

  • Figure Market Size and Growth Rate of Therapeutic

  • Figure Market Size and Growth Rate of Others

  • Table Global Vaccine Adjuvants Production by Major Regions

  • Table Global Vaccine Adjuvants Production Share by Major Regions

  • Figure Global Vaccine Adjuvants Production Share by Major Regions in 2014

  • Figure Global Vaccine Adjuvants Production Share by Major Regions in 2018

  • Figure Global Vaccine Adjuvants Production Share by Major Regions in 2026

  • Table Global Vaccine Adjuvants Consumption by Major Regions

  • Table Global Vaccine Adjuvants Consumption Share by Major Regions

  • Figure Global Vaccine Adjuvants Consumption Share by Major Regions in 2014

  • Figure Global Vaccine Adjuvants Consumption Share by Major Regions in 2018

  • Figure Global Vaccine Adjuvants Consumption Share by Major Regions in 2026

  • Table North America Vaccine Adjuvants Production, Import, Consumption and Export Analysis

  • Table Europe Vaccine Adjuvants Production, Import, Consumption and Export Analysis

  • Table Asia Pacific Vaccine Adjuvants Production, Import, Consumption and Export Analysis

  • Table Latin America, Middle East & Africa Vaccine Adjuvants Production, Import, Consumption and Export Analysis

  • Table Top 5 Export Countries' Export Value Analysis in Vaccine Adjuvants market from 2014 to 2019

  • Table Top 5 Export Countries' Export Volume Analysis in Vaccine Adjuvants market from 2014 to 2019

  • Table Top 5 Import Countries' Import Value Analysis in Vaccine Adjuvants market from 2014 to 2019

  • Table Top 5 Import Countries' Import Volume Analysis in Vaccine Adjuvants market from 2014 to 2019

  • Figure Emerging Top 3 Export Countries Analysis

  • Figure Emerging Top 3 Import Countries Analysis

  • Table North America Vaccine Adjuvants Consumption by Types from 2014 to 2026

  • Table North America Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

  • Figure North America Vaccine Adjuvants Consumption Share by Types in 2014

  • Figure North America Vaccine Adjuvants Consumption Share by Types in 2018

  • Figure North America Vaccine Adjuvants Consumption Share by Types in 2026

  • Table North America Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

  • Table North America Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

  • Figure North America Vaccine Adjuvants Consumption Share by End-Users in 2014

  • Figure North America Vaccine Adjuvants Consumption Share by End-Users in 2018

  • Figure North America Vaccine Adjuvants Consumption Share by End-Users in 2026

  • Table North America Vaccine Adjuvants Consumption by Major Countries from 2014 to 2026

  • Table North America Vaccine Adjuvants Consumption Share by Major Countries from 2014 to 2026

  • Figure North America Vaccine Adjuvants Consumption Share by Major Countries in 2014

  • Figure North America Vaccine Adjuvants Consumption Share by Major Countries in 2018

  • Figure North America Vaccine Adjuvants Consumption Share by Major Countries in 2026

  • Figure United States Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure Canada Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure Mexico Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Table Europe Vaccine Adjuvants Consumption by Types from 2014 to 2026

  • Table Europe Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

  • Figure Europe Vaccine Adjuvants Consumption Share by Types in 2014

  • Figure Europe Vaccine Adjuvants Consumption Share by Types in 2018

  • Figure Europe Vaccine Adjuvants Consumption Share by Types in 2026

  • Table Europe Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

  • Table Europe Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

  • Figure Europe Vaccine Adjuvants Consumption Share by End-Users in 2014

  • Figure Europe Vaccine Adjuvants Consumption Share by End-Users in 2018

  • Figure Europe Vaccine Adjuvants Consumption Share by End-Users in 2026

  • Table Europe Vaccine Adjuvants Consumption by Major Countries from 2014 to 2026

  • Table Europe Vaccine Adjuvants Consumption Share by Major Countries from 2014 to 2026

  • Figure Europe Vaccine Adjuvants Consumption Share by Major Countries in 2014

  • Figure Europe Vaccine Adjuvants Consumption Share by Major Countries in 2018

  • Figure Europe Vaccine Adjuvants Consumption Share by Major Countries in 2026

  • Figure Germany Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure UK Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure France Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure Italy Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure Nordic Countries Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure Belgium Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure Poland Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure Russia Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure Turkey Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Table Asia Pacific Vaccine Adjuvants Consumption by Types from 2014 to 2026

  • Table Asia Pacific Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

  • Figure Asia Pacific Vaccine Adjuvants Consumption Share by Types in 2014

  • Figure Asia Pacific Vaccine Adjuvants Consumption Share by Types in 2018

  • Figure Asia Pacific Vaccine Adjuvants Consumption Share by Types in 2026

  • Table Asia Pacific Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

  • Table Asia Pacific Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

  • Figure Asia Pacific Vaccine Adjuvants Consumption Share by End-Users in 2014

  • Figure Asia Pacific Vaccine Adjuvants Consumption Share by End-Users in 2018

  • Figure Asia Pacific Vaccine Adjuvants Consumption Share by End-Users in 2026

  • Table Asia Pacific Vaccine Adjuvants Consumption by Major Countries from 2014 to 2026

  • Table Asia Pacific Vaccine Adjuvants Consumption Share by Major Countries from 2014 to 2026

  • Figure Asia Pacific Vaccine Adjuvants Consumption Share by Major Countries in 2014

  • Figure Asia Pacific Vaccine Adjuvants Consumption Share by Major Countries in 2018

  • Figure Asia Pacific Vaccine Adjuvants Consumption Share by Major Countries in 2026

  • Figure China Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure Japan Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure Australia and New ZealandVaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure India Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure ASEAN Countries Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure South Korea Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Table Latin America, Middle East & Africa Vaccine Adjuvants Consumption by Types from 2014 to 2026

  • Table Latin America, Middle East & Africa Vaccine Adjuvants Consumption Share by Types from 2014 to 2026

  • Figure Latin America, Middle East & Africa Vaccine Adjuvants Consumption Share by Types in 2014

  • Figure Latin America, Middle East & Africa Vaccine Adjuvants Consumption Share by Types in 2018

  • Figure Latin America, Middle East & Africa Vaccine Adjuvants Consumption Share by Types in 2026

  • Table Latin America, Middle East & Africa Vaccine Adjuvants Consumption by End-Users from 2014 to 2026

  • Table Latin America, Middle East & Africa Vaccine Adjuvants Consumption Share by End-Users from 2014 to 2026

  • Figure Latin America, Middle East & Africa Vaccine Adjuvants Consumption Share by End-Users in 2014

  • Figure Latin America, Middle East & Africa Vaccine Adjuvants Consumption Share by End-Users in 2018

  • Figure Latin America, Middle East & Africa Vaccine Adjuvants Consumption Share by End-Users in 2026

  • Table Latin America, Middle East & Africa Vaccine Adjuvants Consumption by Major Countries from 2014 to 2026

  • Table Latin America, Middle East & Africa Vaccine Adjuvants Consumption Share by Major Countries from 2014 to 2026

  • Figure Latin America, Middle East & Africa Vaccine Adjuvants Consumption Share by Major Countries in 2014

  • Figure Latin America, Middle East & Africa Vaccine Adjuvants Consumption Share by Major Countries in 2018

  • Figure Latin America, Middle East & Africa Vaccine Adjuvants Consumption Share by Major Countries in 2026

  • Figure GCC Countries Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure Brazil Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure Nigeria Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure South Africa Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Figure Argentina Vaccine Adjuvants Market Volume and Growth Rate from 2014 to 2026

  • Table Company Profile and Development Status of Novavax

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novavax

  • Figure Sales and Growth Rate Analysis of Novavax

  • Figure Revenue and Market Share Analysis of Novavax

  • Table Product and Service Introduction of Novavax

  • Table Company Profile and Development Status of Adjuvatis

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adjuvatis

  • Figure Sales and Growth Rate Analysis of Adjuvatis

  • Figure Revenue and Market Share Analysis of Adjuvatis

  • Table Product and Service Introduction of Adjuvatis

  • Table Company Profile and Development Status of Merck KGaA

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA

  • Figure Sales and Growth Rate Analysis of Merck KGaA

  • Figure Revenue and Market Share Analysis of Merck KGaA

  • Table Product and Service Introduction of Merck KGaA

  • Table Company Profile and Development Status of Oz Biosciences

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Oz Biosciences

  • Figure Sales and Growth Rate Analysis of Oz Biosciences

  • Figure Revenue and Market Share Analysis of Oz Biosciences

  • Table Product and Service Introduction of Oz Biosciences

  • Table Company Profile and Development Status of Aphios

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Aphios

  • Figure Sales and Growth Rate Analysis of Aphios

  • Figure Revenue and Market Share Analysis of Aphios

  • Table Product and Service Introduction of Aphios

  • Table Company Profile and Development Status of Seppic

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Seppic

  • Figure Sales and Growth Rate Analysis of Seppic

  • Figure Revenue and Market Share Analysis of Seppic

  • Table Product and Service Introduction of Seppic

  • Table Company Profile and Development Status of SPI Pharma

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SPI Pharma

  • Figure Sales and Growth Rate Analysis of SPI Pharma

  • Figure Revenue and Market Share Analysis of SPI Pharma

  • Table Product and Service Introduction of SPI Pharma

  • Table Company Profile and Development Status of Chemtrade Logistics

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chemtrade Logistics

  • Figure Sales and Growth Rate Analysis of Chemtrade Logistics

  • Figure Revenue and Market Share Analysis of Chemtrade Logistics

  • Table Product and Service Introduction of Chemtrade Logistics

  • Table Company Profile and Development Status of CSL Limited

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CSL Limited

  • Figure Sales and Growth Rate Analysis of CSL Limited

  • Figure Revenue and Market Share Analysis of CSL Limited

  • Table Product and Service Introduction of CSL Limited

  • Table Company Profile and Development Status of Agenus, Inc.

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Agenus, Inc.

  • Figure Sales and Growth Rate Analysis of Agenus, Inc.

  • Figure Revenue and Market Share Analysis of Agenus, Inc.

  • Table Product and Service Introduction of Agenus, Inc.

  • Table Company Profile and Development Status of Invivogen

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Invivogen

  • Figure Sales and Growth Rate Analysis of Invivogen

  • Figure Revenue and Market Share Analysis of Invivogen

  • Table Product and Service Introduction of Invivogen

  • Table Company Profile and Development Status of Brenntag AG

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Brenntag AG

  • Figure Sales and Growth Rate Analysis of Brenntag AG

  • Figure Revenue and Market Share Analysis of Brenntag AG

  • Table Product and Service Introduction of Brenntag AG

  • Table Company Profile and Development Status of InvivoGen

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of InvivoGen

  • Figure Sales and Growth Rate Analysis of InvivoGen

  • Figure Revenue and Market Share Analysis of InvivoGen

  • Table Product and Service Introduction of InvivoGen

  • Table Company Profile and Development Status of Vaxliant

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vaxliant

  • Figure Sales and Growth Rate Analysis of Vaxliant

  • Figure Revenue and Market Share Analysis of Vaxliant

  • Table Product and Service Introduction of Vaxliant

  • Table Company Profile and Development Status of Adjuvance

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adjuvance

  • Figure Sales and Growth Rate Analysis of Adjuvance

  • Figure Revenue and Market Share Analysis of Adjuvance

  • Table Product and Service Introduction of Adjuvance

  • Table Company Profile and Development Status of GlaxoSmithKline

  • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

  • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

  • Figure Revenue and Market Share Analysis of GlaxoSmithKline

  • Table Product and Service Introduction of GlaxoSmithKline


Report Purchase

reports
$4840
$9680
BUY NOWClick MeBUY NOW
top